| Schedule of restatement on each financial statement |
The following tables summarize
the effect of the restatement on each financial statement line item as of the dates, and for the period, indicated:
| |
|
As Previously Reported |
|
|
Adjustment |
|
|
As Restated |
|
| Balance Sheet at November 3, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Liability |
|
$ |
— |
|
|
$ |
15,380,000 |
|
|
$ |
15,380,000 |
|
| Common stock subject to possible redemption |
|
|
94,117,880 |
|
|
|
(15,380,000 |
) |
|
|
78,737,880 |
|
| Common stock |
|
|
406 |
|
|
|
152 |
|
|
|
558 |
|
| Additional paid-in capital |
|
|
5,000,060 |
|
|
|
853,681 |
|
|
|
5,853,741 |
|
| Accumulated deficit |
|
$ |
(461 |
) |
|
$ |
(853,833 |
) |
|
$ |
(854,294 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Balance Sheet at December 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Liability |
|
$ |
— |
|
|
$ |
12,372,000 |
|
|
$ |
12,372,000 |
|
| Common stock subject to possible redemption, |
|
|
108,540,654 |
|
|
|
(12,372,000 |
) |
|
|
96,168,654 |
|
| Common stock |
|
|
418 |
|
|
|
122 |
|
|
|
540 |
|
| Additional paid-in capital |
|
|
5,202,273 |
|
|
|
(4,295,232 |
) |
|
|
907,041 |
|
| Retained earnings (accumulated deficit) |
|
$ |
(202,686 |
) |
|
$ |
4,295,110 |
|
|
$ |
4,092,424 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Statement of Income for the period from August 20, 2020 (inception) through December 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant issuance costs |
|
$ |
— |
|
|
$ |
(973,090 |
) |
|
$ |
(973,090 |
) |
| Unrealized gain on change in fair value of warrants |
|
|
— |
|
|
|
5,268,200 |
|
|
|
5,268,200 |
|
| Net (loss) income |
|
$ |
(202,686 |
) |
|
$ |
4,295,110 |
|
|
$ |
4,092,424 |
|
| Basic and diluted weighted average shares outstanding, common stock subject to redemption |
|
|
4,063,751 |
|
|
|
(664,066 |
) |
|
|
3,399,685 |
|
| Basic and diluted net income per share |
|
$ |
0.00 |
|
|
|
(0.00 |
) |
|
|
0.00 |
|
| Basic and diluted weighted average shares outstanding, common stock |
|
|
3,982,640 |
|
|
|
664,066 |
|
|
|
4,646,706 |
|
| Basic and diluted net (loss) income per share |
|
$ |
(0.05 |
) |
|
$ |
0.93 |
|
|
$ |
0.88 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Statement of Cash Flows for the period from August 20, 2020 (inception) through December 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| Cash Flows from Operating Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
| Net (loss) income |
|
$ |
(202,686 |
) |
|
$ |
4,295,110 |
|
|
$ |
4,092,424 |
|
| Unrealized gain on change in fair value of warrants |
|
|
— |
|
|
|
(5,268,200 |
) |
|
|
(5,268,200 |
) |
| Warrant issuance costs |
|
|
— |
|
|
|
973,090 |
|
|
|
973,090 |
|
|